Vaishali Pharma Ltd.

162.00 +6.20 ▲4.0%

23 April 2024, 03:59:22 PM
Volume: 182,070

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vaishalipharma.com
Market Cap 173.65 Cr.
Enterprise Value(EV) 187.28 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.44 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 29.76 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 35.96 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.51 Calculated using Price: 162.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.07 Cr. 10,719,213 Shares
FaceValue 10
About Vaishali Pharma Ltd.
The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For its export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it has successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

Vaishali Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Vaishali Pharma Ltd. Performance

1 Day
+3.98%
1 Week
+3.22%
1 Month
+17.05%
3 Month
-13.67%
6 Month
+11.69%
1 Year
+9.91%
2 Year
+62.16%
5 Year
+586.73%
10 Year

Vaishali Pharma Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.12 -0.94 19.8 6.49 3.4 0.15 4.78 16.5 22.26
Return on Capital Employed (%) 14.04 12.8 16.18 12.75 9.8 6.89 10.33 18.87 21.92
Return on Assets (%) 0.33 -0.06 1.51 1.47 1.08 0.05 1.38 4.81 8.24

Vaishali Pharma Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 3 4 21 21 21 22 26 41 44
Non Curr. Liab. 8 5 3 3 5 4 4 3 6 5
Curr. Liab. 34 42 37 41 42 40 59 52 32 31
Minority Int.
Equity & Liab. 46 49 45 64 69 66 86 81 79 80
Non Curr. Assets 2 2 5 5 6 5 5 5 6 6
Curr. Assets 44 47 40 59 63 61 81 76 73 74
Misc. Exp. not W/O
Total Assets 46 49 45 64 69 66 86 81 79 80

Vaishali Pharma Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 95 67 64 68 75 60 54 76 70 80
Other Income 4 3 1 2 2 2 2 2 2 2
Total Income 99 70 65 69 77 62 56 78 72 82
Total Expenditure -95 -66 -61 -65 -73 -59 -51 -69 -60 -71
PBIDT 4 4 4 4 4 3 4 9 12 10
Interest -3 -3 -3 -3 -3 -3 -3 -2 -2 -2
Depreciation 0 0 0 0 0 0 0 0 -1 -1
Taxation 0 0 0 -1 0 0 0 -2 -2 -2
Exceptional Items
PAT 0 0 1 1 1 0 1 4 7 6
Adjusted EPS 2 0 1 1 1 0 1 4 6 6

Vaishali Pharma Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -7 -4 5 0 -9 4 3 2 1 1
Cash Fr. Inv. 0 2 3 1 1 0 0 0 -1 0
Cash Fr. Finan. 6 2 -8 -1 9 -4 -3 -2 0 -2
Net Change -1 0 0 0 0 0 0 1 0
Cash & Cash Eqvt 1 1 1 0 0 0 0 0 1 1

Vaishali Pharma Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 26.74 26.74 26.74 26.74 26.74 26.74 26.62 26.62 26.32
Public 73.25 73.26 73.26 73.24 73.26 73.26 73.38 73.38 73.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Vaishali Pharma Ltd. Announcements

Sat, 06 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sat, 30 Mar 2024
Trading Window-XBRL
VAISHALI PHARMA LIMITED has informed the Exchange about Closure of Trading Window
Sat, 30 Mar 2024
Trading Window
Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Vaishali Pharma Ltd. Technical Scans

Tue, 23 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Making Lower Lows for 3 days Making Lower Lows for 3 days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

Vaishali Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Vaishali Pharma Ltd. FAQ's

What is Vaishali Pharma share price?

Can I buy Vaishali Pharma shares now?

What is the Market Cap of Vaishali Pharma?

What are the key metrics to analyse Vaishali Pharma?

What is the 52 Week High and Low of Vaishali Pharma?

What is the trend of Vaishali Pharma share price?